UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.433

Sortiert nach

Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV

The Journal of clinical investigation, 2011-01, Vol.121 (1), p.308-317

2011

Link zum Volltext

Verfügbarkeit prüfen

Dynamic Changes of Post-Translationally Modified Forms of CXCL10 and Soluble DPP4 in HCV Subjects Receiving Interferon-Free Therapy

PloS one, 2015-07, Vol.10 (7), p.e0133236-e0133236

2015

Link zum Volltext

Verfügbarkeit prüfen

Plasma levels of DPP4 activity and sDPP4 are dissociated from inflammation in mice and humans

Nature communications, 2020-07, Vol.11 (1), p.3766-12, Article 3766

2020

Link zum Volltext

Verfügbarkeit prüfen

Soybean- and Lupin-Derived Peptides Inhibit DPP-IV Activity on In Situ Human Intestinal Caco-2 Cells and Ex Vivo Human Serum

Nutrients, 2018-08, Vol.10 (8), p.1082

2018

Link zum Volltext

Verfügbarkeit prüfen

Identification and validation of novel contraction-regulated myokines released from primary human skeletal muscle cells

PloS one, 2013-04, Vol.8 (4), p.e62008-e62008

2013

Link zum Volltext

Verfügbarkeit prüfen

Activatable Near-Infrared Fluorescent Probe for Dipeptidyl Peptidase IV and Its Bioimaging Applications in Living Cells and Animals

Analytical chemistry (Washington), 2018-03, Vol.90 (6), p.3965-3973

2018

Link zum Volltext

Verfügbarkeit prüfen

A highly specific ratiometric two-photon fluorescent probe to detect dipeptidyl peptidase IV in plasma and living systems

Biosensors & bioelectronics, 2017-04, Vol.90, p.283-289

2017

Link zum Volltext

Verfügbarkeit prüfen

The protective role of DPP4 inhibitors in atherosclerosis

European journal of pharmacology, 2020-05, Vol.875, p.173037-173037, Article 173037

2020

Link zum Volltext

Verfügbarkeit prüfen

Tezepelumab, an anti–thymic stromal lymphopoietin monoclonal antibody, in the treatment of moderate to severe atopic dermatitis: A randomized phase 2a clinical trial

Journal of the American Academy of Dermatology, 2019-04, Vol.80 (4), p.1013-1021

2019

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of dipeptidyl peptidase IV prevents high fat diet-induced liver cancer angiogenesis by downregulating chemokine ligand 2

Cancer letters, 2018-04, Vol.420, p.26-37

2018

Link zum Volltext

Verfügbarkeit prüfen

The role of adipokines in β-cell failure of type 2 diabetes

Journal of endocrinology, 2013-01, Vol.216 (1), p.T37-T45

2013

Link zum Volltext

Verfügbarkeit prüfen

Elevated hepatic DPP4 activity promotes insulin resistance and non-alcoholic fatty liver disease

Molecular metabolism (Germany), 2017-10, Vol.6 (10), p.1254-1263

2017

Link zum Volltext

Verfügbarkeit prüfen

Dipeptidyl Peptidase-4 Modulates Left Ventricular Dysfunction in Chronic Heart Failure via Angiogenesis-Dependent and -Independent Actions

Circulation (New York, N.Y.), 2012-10, Vol.126 (15), p.1838-1851

2012

Link zum Volltext

Verfügbarkeit prüfen

Reduction of soluble dipeptidyl peptidase 4 levels in plasma of patients infected with Middle East respiratory syndrome coronavirus

Virology (New York, N.Y.), 2018-05, Vol.518, p.324-327

2018

Link zum Volltext

Verfügbarkeit prüfen

Gliptin-mediated neuroprotection against stroke requires chronic pretreatment and is independent of glucagon-like peptide-1 receptor

Diabetes, obesity & metabolism, 2016-05, Vol.18 (5), p.537-541

2016

Link zum Volltext

Verfügbarkeit prüfen

Significance of circulatory DPP4 activity in metabolic diseases

IUBMB life, 2018-02, Vol.70 (2), p.112-119

2018

Link zum Volltext

Verfügbarkeit prüfen

Increased dipeptidyl peptidase-4 accelerates diet-related vascular aging and atherosclerosis in ApoE-deficient mice under chronic stress

International journal of cardiology, 2017-09, Vol.243, p.413-420

2017

Link zum Volltext

Verfügbarkeit prüfen

Cellular Sites and Mechanisms Linking Reduction of Dipeptidyl Peptidase-4 Activity to Control of Incretin Hormone Action and Glucose Homeostasis

Cell metabolism, 2017-01, Vol.25 (1), p.152-165

2017

Link zum Volltext

Verfügbarkeit prüfen

Dipeptidyl peptidase‐4 inhibitor improves neovascularization by increasing circulating endothelial progenitor cells

British journal of pharmacology, 2012-12, Vol.167 (7), p.1506-1519

2012

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic–pharmacodynamic (dipeptidyl peptidase‐4 inhibition) model to support dose rationale in diabetes patients, including those with renal impairment, for once‐weekly administered omarigliptin

British journal of clinical pharmacology, 2019-12, Vol.85 (12), p.2759-2771

2019

Link zum Volltext

Verfügbarkeit prüfen

First-in-human phase 1 of YS110, a monoclonal antibody directed against CD26 in advanced CD26-expressing cancers

British journal of cancer, 2017-04, Vol.116 (9), p.1126-1134

2017

Link zum Volltext

Verfügbarkeit prüfen

Human Th17 cells express high levels of enzymatically active dipeptidylpeptidase IV (CD26)

The Journal of immunology (1950), 2012-06, Vol.188 (11), p.5438-5447

2012

Link zum Volltext

Verfügbarkeit prüfen

Food protein hydrolysates as a source of dipeptidyl peptidase IV inhibitory peptides for the management of type 2 diabetes

Proceedings of the Nutrition Society, 2014-02, Vol.73 (1), p.34-46

2014

Link zum Volltext

Verfügbarkeit prüfen

Circulating levels of soluble Dipeptidylpeptidase-4 are reduced in human subjects hospitalized for severe COVID-19 infections

International Journal of Obesity, 2020-11, Vol.44 (11), p.2335-2338

2020

Link zum Volltext

Verfügbarkeit prüfen

Elevated Human Dipeptidyl Peptidase 4 Expression Reduces the Susceptibility of hDPP4 Transgenic Mice to Middle East Respiratory Syndrome Coronavirus Infection and Disease

The Journal of infectious diseases, 2019-02, Vol.219 (5), p.829-835

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.433

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.252)
Mit Volltextzugriff
(1.264)

Publikationsform

Artikel
(1.433)

Sprache

7 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.308)
Life Sciences & Biomedicine
(1.244)
Humans
(1.062)
Male
(780)
Animals
(611)
Dipeptidyl Peptidase 4 - Metabolism
(564)
Female
(554)
Dipeptidyl Peptidase 4 - Blood
(433)
Endocrinology & Metabolism
(421)
Middle Aged
(414)
Diabetes Mellitus, Type 2 - Drug Therapy
(406)
Diabetes
(356)
Adult
(333)
Biological And Medical Sciences
(305)
Blood Glucose - Metabolism
(299)
Aged
(281)
Dipeptidyl-Peptidase Iv Inhibitors - Therapeutic Use
(273)
Pharmacology & Pharmacy
(262)
Diabetes Mellitus, Type 2 - Blood
(252)
Rats
(252)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV

Dynamic Changes of Post-Translationally Modified Forms of CXCL10 and Soluble DPP4 in HCV Subjects Receiving Interferon-Free Therapy

Plasma levels of DPP4 activity and sDPP4 are dissociated from inflammation in mice and humans

Soybean- and Lupin-Derived Peptides Inhibit DPP-IV Activity on In Situ Human Intestinal Caco-2 Cells and Ex Vivo Human Serum

Identification and validation of novel contraction-regulated myokines released from primary human skeletal muscle cells

Activatable Near-Infrared Fluorescent Probe for Dipeptidyl Peptidase IV and Its Bioimaging Applications in Living Cells and Animals

A highly specific ratiometric two-photon fluorescent probe to detect dipeptidyl peptidase IV in plasma and living systems

The protective role of DPP4 inhibitors in atherosclerosis

Tezepelumab, an anti–thymic stromal lymphopoietin monoclonal antibody, in the treatment of moderate to severe atopic dermatitis: A randomized phase 2a clinical trial

Inhibition of dipeptidyl peptidase IV prevents high fat diet-induced liver cancer angiogenesis by downregulating chemokine ligand 2

The role of adipokines in β-cell failure of type 2 diabetes

Elevated hepatic DPP4 activity promotes insulin resistance and non-alcoholic fatty liver disease

Dipeptidyl Peptidase-4 Modulates Left Ventricular Dysfunction in Chronic Heart Failure via Angiogenesis-Dependent and -Independent Actions

Reduction of soluble dipeptidyl peptidase 4 levels in plasma of patients infected with Middle East respiratory syndrome coronavirus

Gliptin-mediated neuroprotection against stroke requires chronic pretreatment and is independent of glucagon-like peptide-1 receptor

Significance of circulatory DPP4 activity in metabolic diseases

Increased dipeptidyl peptidase-4 accelerates diet-related vascular aging and atherosclerosis in ApoE-deficient mice under chronic stress

Cellular Sites and Mechanisms Linking Reduction of Dipeptidyl Peptidase-4 Activity to Control of Incretin Hormone Action and Glucose Homeostasis

Dipeptidyl peptidase‐4 inhibitor improves neovascularization by increasing circulating endothelial progenitor cells

Pharmacokinetic–pharmacodynamic (dipeptidyl peptidase‐4 inhibition) model to support dose rationale in diabetes patients, including those with renal impairment, for once‐weekly administered omarigliptin

First-in-human phase 1 of YS110, a monoclonal antibody directed against CD26 in advanced CD26-expressing cancers

Human Th17 cells express high levels of enzymatically active dipeptidylpeptidase IV (CD26)

Food protein hydrolysates as a source of dipeptidyl peptidase IV inhibitory peptides for the management of type 2 diabetes

Circulating levels of soluble Dipeptidylpeptidase-4 are reduced in human subjects hospitalized for severe COVID-19 infections

Elevated Human Dipeptidyl Peptidase 4 Expression Reduces the Susceptibility of hDPP4 Transgenic Mice to Middle East Respiratory Syndrome Coronavirus Infection and Disease

Suchergebnisse filtern